AIMS
The aims of the present study were to evaluate the risk of cardiac failure (CF) associated with 15 anticancer protein kinase inhibitors (PKIs) through a case/noncase analysis and to identify which PK(s) and pathways are involved in PKI-induced CF.
METHODS
In order to evaluate the risk of CF, adjusted reporting odds ratios (aRORs) were calculated for… CONTINUE READING